BPGbio
John is responsible for developing and executing corporate strategy, identifying new business models, and building commercial partnerships to accelerate the advancement of BPGbio’s clinical-stage assets.
Prior to BPGbio he led strategy and investments for Innova Medical Group and was a Principal at Pasaca Capital. Before joining Pasaca he advised clients in the Technology and Precision Biology sectors on M&A and capital formation at Citigroup. He began his career as an aerospace engineer. John received his MBA from UCLA and his bachelor’s and master’s degrees in engineering from USC.
This person is not in any offices
BPGbio
BPGbio is a clinical-stage biopharma reimagining how patient biology can be modeled using unbiased AI algorithms, to accelerate and de-risk the process of drug discovery for humanity.